¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ º´Çà) 2020³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ : 2020-08-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ º´Çà) 2020³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ : 2020-08-22
±³À°ÀÏÀÚ : 2020-08-22
±³À°Àå¼Ò : ¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ ¿¬¼ö±³À° (¿ÀÇÁ¶óÀÎ: ´ë±¸ È£ÅÚÀÎÅÍºÒ°í ¿¢½ºÄÚ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ º´Çà) 2020³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ (8/22)      
ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320  
À̸ÞÀÏ : office@thyroid.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í Çмú´ëȸ 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø, 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 08:30~08:45 Operative Management of Primary Papillary Thyroid Carcinoma  ±è¿Ï¿í(°æºÏÀÇ´ë ¿Ü°ú) 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 08:45~09:00 Optimal Management for the Locally Invasive Thyroid Cancer  ¾È¼øÇö(¼­¿ïÀÇ´ë À̺ñÀÎÈÄ°ú) 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 09:00~09:15 Optimal Neck Dissection: How Much Surgery is Enough for the Node Positive Neck?  À̺´ÁÖ(ºÎ»êÀÇ´ë À̺ñÀÎÈÄ°ú) 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 09:15~09:30 Intraoperative Neuromonitoring during Thyroid Surgery  ±èÈÆ¿±(°í·ÁÀÇ´ë ¿Ü°ú) 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 09:45~10:05 Immune Landscape of Papillary Thyroid Cancer and Immunotherapeutic Implications  ÃÖÈ«À±(¼­¿ïÀÇ´ë ÇÙÀÇÇаú) 
Åä·Ð 08¿ù 22ÀÏ ±×·£µåº¼·ë 10:05~10:25 Co-Expression Network Analysis with Proteogenomics Identifies Important Transcriptional Factors in Tumorigenesis and Progression of BRAFV600E Mutated Thyroid Cancer  ±èÀ¯Çü(¼­¿ïÀÇ´ë ³»°ú) 
Åä·Ð 08¿ù 22ÀÏ ±×·£µåº¼·ë 10:25~10:45 Macrophage-Derived Endotrophin Supports Tumor Migration Potentials in Thyroid Cancer  ½ÅÈ¿½Ä(¼­¿ïÀÇ´ë ³»°ú) 
È޽Ġ08¿ù 22ÀÏ ±×·£µåº¼·ë 10:55~11:15 Coffee Break  () 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 11:15~12:15 Current Surgical Management of Thyroid Cancer in the United States  Quan-Yang Duh(University of California San Francisco) 
±âŸ 08¿ù 22ÀÏ ±×·£µåº¼·ë 12:15~12:45 ÃÑȸ  () 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 12:45~13:20 Metabolic Issues to Consider When Treating Patients with Thyroid Disease  ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú) 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 13:30~14:10 Metastatic Follicular Carcinoma in Pelvic Cavity Arising Struma Ovarii  Á¤Á¾±æ(¿©¼öÀü³²º´¿ø ¿Ü°ú) 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 14:15~15:00 Development of New Technologies on the Preservation of the Parathyroid Gland and Recurrent Laryngeal Nerve during Thyroid and Parathyroid Surgery  ÀÌ°­´ë(°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú) 
È޽Ġ08¿ù 22ÀÏ ±×·£µåº¼·ë 15:00~15:20 Coffee Break  () 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 15:20~15:40 Role of Thyroid US and CT in Active Surveillance of Low-Risk PTMC  ¾ÈÇý½Å(Áß¾ÓÀÇ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 15:40~16:00 Interventional Management of Low-Risk PTMC  ÇÏÀºÁÖ(¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú) 
±³À°½Ã°£ 08¿ù 22ÀÏ ±×·£µåº¼·ë 16:00~16:20 Current Stance on Active Surveillance of Low-Risk PTMC  ¼Û¿µ±â(¿ï»êÀÇ´ë ³»°ú) 
±âŸ 08¿ù 22ÀÏ ±×·£µåº¼·ë 16:35~17:45 Topic Highlight  () 
±âŸ 08¿ù 22ÀÏ ¾ÆÀ̸®½ºÈ¦ 08:30~09:10 Free Paper 3  () 
±âŸ 08¿ù 22ÀÏ ¾ÆÀ̸®½ºÈ¦ 09:10~09:50 Free Paper 4  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ º´Çà) 2020³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ : 2020-08-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) 2020 Seoul Medical Symposium (Á¦18Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ) : 2020-08-22
´ÙÀ½±Û ´ëÇѼÒÈ­±â¾ÏÇÐȸ (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) KSGC 2020 : 2020-08-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 5 15:07:03
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 4 15:04:54
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 3 15:03:12
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 3 15:01:06
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 2 14:59:21
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 0 14:57:48
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 0 14:56:11
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 0 14:53:49
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 0 14:52:21
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 0 14:50:56
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 0 14:49:27
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 0 14:48:12
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 0 14:46:55
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 1 14:45:22
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 1 14:43:02
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷